跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
VENLAFAXINE APL XR venlafaxine (as hydrochloride) 225 mg modified release capsule
Approved
STANDARD
VENLAFAXINE APL XR venlafaxine (as hydrochloride) 225 mg modified release capsule
Alembic Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
23170756a652a2d4
Company
Alembic Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
23170756a652a2d4
Product Name
VENLAFAXINE APL XR venlafaxine (as hydrochloride) 225 mg modified release capsule
Artg Id
292638
Artg Name
VENLAFAXINE APL XR venlafaxine (as hydrochloride) 225 mg modified release capsule
Sponsor
Alembic Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/alembic-pharmaceuticals-australia-pty-ltd
Artg Date
2018-08-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
23170756a652a2d4
Type
Standard
Back to TGA Approvals
VENLAFAXINE APL XR venlafaxine (as hydrochloride) 225 mg modified release capsule - TGA Drug Approval Details
